PhD4GlycoDrug
Third-party funded project
Project title PhD4GlycoDrug
Principal Investigator(s) Ricklin, Daniel
Co-Investigator(s) Schwardt, Oliver
Organisation / Research unit Departement Pharmazeutische Wissenschaften / Molekulare Pharmazie (Ricklin),
Departement Pharmazeutische Wissenschaften / Molekulare Pharmazie (Ernst)
Project Website https://www.phd4glycodrug.eu
Project start 01.10.2017
Probable end 30.09.2021
Status Active
Abstract

The PhD4GlycoDrug consortium has a main goal to offer a European Joint Doctorate educational training network in Glyco-Drug Discovery and Development. The network combines 6 academic partners with long tradition in PhD training and accredited doctoral studies in Organic Chemistry, Medicinal Chemistry, Structural Biology and Pharmacology/Pharmacy. Non-academic partners, 4 SMEs and a research institute also constitute the consortium to offer intersectoral exposure and quality training in transferable skills to entrepreneurial ESRs. So far, only a handful of registered drugs originate from glycoscience area. To pursue an innovative research project in such a timely scientific field of great interest for pharmaceutical industry, a specific set of competences is needed. Our network will focus on delivering expert researchers highly attractive for employment by the European Pharma-industry.

Financed by Commission of the European Union
   

MCSS v5.8 PRO. 0.451 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
12/08/2020